Logo image of KVUE

KENVUE INC (KVUE) Stock Overview

NYSE:KVUE - US49177J1025 - Common Stock

18.87 USD
+0.38 (+2.03%)
Last: 9/9/2025, 8:04:00 PM
18.85 USD
-0.02 (-0.11%)
After Hours: 9/9/2025, 8:04:00 PM

KVUE Key Statistics, Chart & Performance

Key Statistics
52 Week High25.17
52 Week Low17.15
Market Cap36.21B
Shares1.92B
Float1.92B
Yearly Dividend0.81
Dividend Yield4.04%
EPS(TTM)1.07
PE17.64
Fwd PE16.28
Earnings (Next)11-05 2025-11-05/bmo
IPO05-04 2023-05-04
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products


KVUE short term performance overview.The bars show the price performance of KVUE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

KVUE long term performance overview.The bars show the price performance of KVUE in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15

The current stock price of KVUE is 18.87 USD. In the past month the price decreased by -11.07%. In the past year, price decreased by -19.32%.

KENVUE INC / KVUE Daily stock chart

KVUE Competitors/Peers

The largest stocks on the US markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
UL UNILEVER PLC-SPONSORED ADR 23.8 154.66B
EL ESTEE LAUDER COMPANIES-CL A 59.13 31.92B
ELF ELF BEAUTY INC 43.66 7.88B
BRBR BELLRING BRANDS INC 17.38 4.75B
IPAR INTERPARFUMS INC 22.65 3.72B
COTY COTY INC-CL A 19.32 3.71B
ODD ODDITY TECH LTD-CL A 29.87 3.55B
EPC EDGEWELL PERSONAL CARE CO 8.69 1.04B
YSG YATSEN HOLDING LTD-ADR N/A 1.02B
HLF HERBALIFE LTD 4.49 977.48M
OLPX OLAPLEX HOLDINGS INC 18.13 967.27M
NUS NU SKIN ENTERPRISES INC - A 9.59 574.20M

About KVUE

Company Profile

KVUE logo image Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Company Info

KENVUE INC

1 Kenvue Way

Summit NEW JERSEY US

Employees: 22000

KVUE Company Website

KVUE Investor Relations

Phone: 19088741200

KENVUE INC / KVUE FAQ

What is the stock price of KENVUE INC today?

The current stock price of KVUE is 18.87 USD. The price increased by 2.03% in the last trading session.


What is the ticker symbol for KENVUE INC stock?

The exchange symbol of KENVUE INC is KVUE and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is KVUE stock listed?

KVUE stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for KENVUE INC stock?

24 analysts have analysed KVUE and the average price target is 23.14 USD. This implies a price increase of 22.63% is expected in the next year compared to the current price of 18.87. Check the KENVUE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is KENVUE INC worth?

KENVUE INC (KVUE) has a market capitalization of 36.21B USD. This makes KVUE a Large Cap stock.


How many employees does KENVUE INC have?

KENVUE INC (KVUE) currently has 22000 employees.


What are the support and resistance levels for KENVUE INC (KVUE) stock?

KENVUE INC (KVUE) has a support level at 18.62 and a resistance level at 20.74. Check the full technical report for a detailed analysis of KVUE support and resistance levels.


Is KENVUE INC (KVUE) expected to grow?

The Revenue of KENVUE INC (KVUE) is expected to decline by -2.56% in the next year. Check the estimates tab for more information on the KVUE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy KENVUE INC (KVUE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does KENVUE INC (KVUE) stock pay dividends?

KENVUE INC (KVUE) has a dividend yield of 4.04%. The yearly dividend amount is currently 0.81. Check the full fundamental report for a detailed analysis of KVUE dividend history, reliability and sustainability.


When does KENVUE INC (KVUE) report earnings?

KENVUE INC (KVUE) will report earnings on 2025-11-05, before the market open.


What is the Price/Earnings (PE) ratio of KENVUE INC (KVUE)?

The PE ratio for KENVUE INC (KVUE) is 17.64. This is based on the reported non-GAAP earnings per share of 1.07 and the current share price of 18.87 USD. Check the full fundamental report for a full analysis of the valuation metrics for KVUE.


What is the Short Interest ratio of KENVUE INC (KVUE) stock?

The outstanding short interest for KENVUE INC (KVUE) is 2.31% of its float. Check the ownership tab for more information on the KVUE short interest.


KVUE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

KVUE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to KVUE. There are concerns on the financial health of KVUE while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

KVUE Financial Highlights

Over the last trailing twelve months KVUE reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS decreased by -12.3% compared to the year before.


Industry RankSector Rank
PM (TTM) 9.37%
ROA 5.23%
ROE 13.22%
Debt/Equity 0.73
Chartmill High Growth Momentum
EPS Q2Q%-9.38%
Sales Q2Q%-4.03%
EPS 1Y (TTM)-12.3%
Revenue 1Y (TTM)-2.16%

KVUE Forecast & Estimates

24 analysts have analysed KVUE and the average price target is 23.14 USD. This implies a price increase of 22.63% is expected in the next year compared to the current price of 18.87.

For the next year, analysts expect an EPS growth of -6.74% and a revenue growth -2.56% for KVUE


Analysts
Analysts70
Price Target23.14 (22.63%)
EPS Next Y-6.74%
Revenue Next Year-2.56%

KVUE Ownership

Ownership
Inst Owners101.39%
Ins Owners0.04%
Short Float %2.31%
Short Ratio2.48